Knee Kinesiography for Anterior Knee Pain
Trial Summary
What is the purpose of this trial?
This is a randomized clinical trial investigating the use of the Emovi Knee Kinesiography information in the treatment of anterior knee pain in physical therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Emovi 3D Knee Assessment Device, KneeKG, Knee Kinesiography System for anterior knee pain?
Is the KneeKG system safe for use in humans?
How does the Emovi 3D Knee Assessment Device treatment differ from other treatments for anterior knee pain?
The Emovi 3D Knee Assessment Device, also known as KneeKG, is unique because it provides a detailed three-dimensional analysis of knee movement, which helps in accurately diagnosing and evaluating knee conditions. Unlike traditional methods, it uses a non-invasive exoskeleton attachment system to reduce errors caused by skin movement, offering a more precise assessment of knee joint motion.17101112
Research Team
Don L Goss, DPT, PhD
Principal Investigator
Womack Army Medical Center
Eligibility Criteria
This trial is for active duty service members aged 18-50 stationed at Fort Liberty and Schofield Barracks, diagnosed with patellofemoral pain. It's not open to those with a history of traumatic knee injury, rheumatoid or neurological diseases, previous knee surgery, other lower limb injuries, individuals moving from the station within three months, or pregnant women.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline measures and receive a Knee Kinesiography exam
Treatment
Participants receive either KneeKG informed care or usual care for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Emovi 3D Knee Assessment Device
Emovi 3D Knee Assessment Device is already approved in United States, Canada, European Union for the following indications:
- Assessment of knee motion for patients with impaired movement functions of an orthopedic cause
- Assessment of knee motion for patients with impaired movement functions of an orthopedic cause
- Assessment of knee motion for patients with impaired movement functions of an orthopedic cause
Find a Clinic Near You
Who Is Running the Clinical Trial?
Womack Army Medical Center
Lead Sponsor
Medical Technology Enterprise Consortium
Collaborator
The Geneva Foundation
Collaborator